We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This guidance clarifies the expectations on the application of the EU guidance on good pharmacovigilance practices (GVP)
How to write clear and effective field safety notices (FSNs) for medical devices.
How to register on the MHRA portal and use it to apply for and update marketing authorisations and make other applications.
Guidance for UK wholesalers and manufacturers on how to import human medicines including unlicensed medicines, how to apply for a licence and how much it costs.
How the MHRA makes decisions on whether a borderline product is a medical device and which risk class should apply.
How to apply for a traditional herbal registration (THR) to market a herbal medicine in the UK.
A step-by-step guide on using the MORE Platform for Submissions of device related incidents.
Keep up to date with the latest information from the UK GLP monitoring authority.
Guidance on transitional arrangements for applying for clinical trial approval.
What you need to do before your product can be placed on the Great Britain market with a UKCA mark.
Details of the organisations that are currently approved to undertake conformity assessments on medical devices.
There are changes to the legislation on reference medicinal products (RMPs) used to support abridged marketing authorisation applications.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines
How to submit your periodic safety update report report (PSUR) or periodic benefit risk evaluation report (PBRER)
Guidance on categorising certain clinical trials as ‘notifiable’.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
How the MHRA makes decisions on what is a medicinal product (borderline products).
How to use the procedure for medicines licensing applications.
Information and recommendations for manufacturers on the preparation and presentation of a periodic safety update report (PSUR).
Information and recommendations for approved bodies on the presentation and review of a periodic safety update report (PSUR).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).